(Reuters) Hedge funds have trimmed bets on a fall in shares of Clariant (CLN.S), just as activist investor Corvex increases pressure on the Swiss chemicals company to ditch a $20 billion M&A deal with rival Huntsman (HUN.N). The hedge funds’ action shows some may have been squeezed by a rise in Clariant shares but also potentially points to some scepticism that Corvex will succeed in scuppering the deal.
Clariant Short-Sellers Squeezed as Activist Corvex Doubles-Down
This entry was posted in Syndicated. Bookmark the permalink.
